Hepatic impairment Administration of tapentadol resulted in better exposures and serum stages to tapentadol in subjects with impaired hepatic operate in comparison to topics with normal hepatic function. The ratio of tapentadol pharmacokinetic parameters for that mild and moderate hepatic impairment groups in comparison to the traditional hepatic f